A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies | NeoGenomics Laboratories

Publication date

Mon, 10/01/2018 - 12:00

Year

Subtitle

Published in Journal of Clinical Pathology, October 2018

External link

https://www.ncbi.nlm.nih.gov/pubmed/30275099